Cardlytics(US:CDLX)2023-11-09 04:16Financial Performance - Consolidated revenue for Q3 2023 reached $79.0 million, representing an 8.7% year-over-year increase[5, 31] - Billings grew by 5.5% year-over-year to $116.4 million in Q3 2023[5, 62] - Adjusted contribution rose by 22.0% year-over-year to $42.86 million, with an adjusted contribution margin of 54.3%[5, 62] - Gross profit improved significantly by 37.8% year-over-year to $35.85 million[5, 62] - Adjusted EBITDA turned positive at $3.95 million in Q3 2023, compared to a loss of $12.71 million in Q3 2022[5, 62] Operational Metrics - Monthly Active Users (MAUs) increased to 162.5 million, a 4.0% growth compared to the same period in 2022[62] - Average Revenue Per User (ARPU) for the Cardlytics platform reached $0.49, up 4.3% year-over-year[62] Guidance and Outlook - Q4 2023 revenue guidance is projected between $82.0 million and $90.0 million[63, 67] - Q4 2023 billings are forecasted to be in the range of $122.0 million to $133.0 million[63, 67] - Q4 2023 adjusted contribution is expected to range from $44.0 million to $50.0 million[63]